118 related articles for article (PubMed ID: 4843743)
1. A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenaemia.
Rosenberg RD; Colman RW; Lorand L
Br J Haematol; 1974 Feb; 26(2):269-84. PubMed ID: 4843743
[No Abstract] [Full Text] [Related]
2. Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII).
Lorand L; Maldonado N; Fradera J; Atencio AC; Robertson B; Urayama T
Br J Haematol; 1972 Jul; 23(1):17-27. PubMed ID: 5045959
[No Abstract] [Full Text] [Related]
3. [Rational diagnosis in blood coagulation disorders].
Spannagl M; Schramm W
Internist (Berl); 1994 Jul; 35(7):646-51. PubMed ID: 7928167
[No Abstract] [Full Text] [Related]
4. An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations.
Otis PT; Feinstein DI; Rapaport SI; Patch MJ
Blood; 1974 Dec; 44(6):771-81. PubMed ID: 4214572
[No Abstract] [Full Text] [Related]
5. Acquired plasma factor XIII deficiencies.
Tosetto A; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):5-10. PubMed ID: 8039759
[TBL] [Abstract][Full Text] [Related]
6. The fibrin stabilizing factor, factor XIII.
Duckert F
Blut; 1973 Mar; 26(3):177-9. PubMed ID: 4571301
[No Abstract] [Full Text] [Related]
7. An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin cross-linking.
Fear JD; Miloszewski KJ; Losowsky MS
Acta Haematol; 1984; 71(5):304-9. PubMed ID: 6429995
[TBL] [Abstract][Full Text] [Related]
8. [Coagulation physiology research in a new coagulation disorder. Deficiency of a fibrin-stabilizing factor].
DUCKERT F; JUNG E; SHMERLING DH
Schweiz Med Wochenschr; 1961 Sep; 91():1139-40. PubMed ID: 13888166
[No Abstract] [Full Text] [Related]
9. A haemorrhagic disorder in pregnancy due to an "anticoagulant" preventing the conversion of fibrinogen to fibrin.
BAKER SJ; JACOB E
J Clin Pathol; 1960 May; 13(3):214-9. PubMed ID: 13796035
[TBL] [Abstract][Full Text] [Related]
10. [Blind spots of the diagnostic hemostasis screen].
Levi M; Peters M; Briët E
Ned Tijdschr Geneeskd; 2000 Mar; 144(10):457-60. PubMed ID: 10726152
[TBL] [Abstract][Full Text] [Related]
11. Hemorrhagic disease associated with inhibitors of fibrin cross-linkage.
Lewis JH
Ann N Y Acad Sci; 1972 Dec; 202():213-9. PubMed ID: 4508924
[No Abstract] [Full Text] [Related]
12. [Increased thrombin time in a patient with multiple myeloma].
Bohler A; Redondo M; Lämmle B
Ther Umsch; 1999 Sep; 56(9):491-4. PubMed ID: 10517116
[TBL] [Abstract][Full Text] [Related]
13. DEFECTIVE FIBRINASE ACTIVITY IN TWO BROTHERS.
HAMPTON JW; BIRD RM; HAMMARSTEN DM
J Lab Clin Med; 1965 Mar; 65():469-74. PubMed ID: 14261328
[No Abstract] [Full Text] [Related]
14. Cryofibrinogenaemia and skin ulcers: treatment with plasmapheresis.
Copeman PW
Br J Dermatol; 1979 Jul; 101 Suppl 17():57-8. PubMed ID: 465341
[No Abstract] [Full Text] [Related]
15. [Relation between fibrinogen concentration, fibrin-stabilizing factor activity and fibrinolysis in hemorrhagic disease in children].
Bebeshko VG; Donskaia SB
Lab Delo; 1987; (7):520-2. PubMed ID: 2442484
[No Abstract] [Full Text] [Related]
16. [Anomaly of polymerization of fibrin in a case of gamma-A myeloma].
Krick JA; Ménaché D
Nouv Rev Fr Hematol; 1966; 6(5):744-8. PubMed ID: 4165868
[No Abstract] [Full Text] [Related]
17. A painful bleeding syndrome associated with increased fibrinolytic activity.
Rowell NR
Br J Dermatol; 1974 Nov; 91(5):591-6. PubMed ID: 4433477
[No Abstract] [Full Text] [Related]
18. CONGENITAL DEFICIENCY OF FIBRIN-STABILIZING FACTOR. OBSERVATION OF A NEW CASE.
BARRY A; DELAGE JM
N Engl J Med; 1965 May; 272():943-7. PubMed ID: 14274451
[No Abstract] [Full Text] [Related]
19. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.
ALKJAERSIG N; FLETCHER AP; SHERRY S
J Clin Invest; 1962 Apr; 41(4):917-34. PubMed ID: 13860492
[No Abstract] [Full Text] [Related]
20. [Electrophoretic studies on fibrinogen subunits and factor-XIII+-stabilized fibrin, from normal and cobalt-treated rabbits].
Krantz S; Lober M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(3):295-302. PubMed ID: 4130627
[No Abstract] [Full Text] [Related]
[Next] [New Search]
